Zyla Life Sciences is committed to bringing important products to patients and healthcare providers. We currently are focused on marketing our portfolio of seven approved medicines for pain and inflammation. To augment our product portfolio, we are seeking to acquire additional product candidates or approved products to develop and commercialize in areas consistent with our current focus or complementary therapeutic areas.
For more information about our medicines, including boxed warnings, please visit www.zyla.com/medicines.